ArticleBlood2011

A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies.

Karl-Heinz Heider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.